We noticed you are on our UK page. Want to switch regions? Choose from the options:

MRIdian radiotherapy for prostate cancer

The latest game-changing treatment for prostate cancer

Precision radiotherapy

We provide specialist cancer care that focuses on innovating the latest, evidence-based treatments from around the world. We are proud to be the first healthcare provider in the UK to introduce the MRIdian MR linac. This smart radiation technology combines high-resolution magnetic resonance imaging (MRI) techniques with extremely precise radiotherapy beams that can treat tumours more accurately than conventional radiotherapy. This type of radiotherapy is called MRI-guided radiotherapy.

The MRIdian is considered ground-breaking because it is able to turn on the radiation beam only when the tumour is positioned precisely in the treatment window and turn off the beam in an instant if the tumour moves even by a fraction – helping to protect normal tissue from unnecessary radiation exposure. No other radiotherapy technology in the UK is currently able to achieve this.

Benefits of the MRIdian for prostate cancer

The MRIdian provides a type of radiotherapy called stereotactic ablative radiotherapy (SABR), which is often used for prostate cancer. However, unlike conventional SABR, MRIdian has the advantage that it can see and adjust for every movement during treatment.

Enquire now about the MRIdian

The MRIdian is available at our centres in Oxford and Cromwell Hospital in London. Your cancer specialist can refer you for a consultation. We’re recognised by all major insurers and we’ll help you with transport depending on treatment and locations, when required.

Radiotherapy for prostate cancer treatment

Radiotherapy is often preferred over surgery for prostate cancer as a less invasive treatment option and provides similar rates of cure. Having radiotherapy on the MRIdian may be suitable for you if your prostate is not too large and your urinary symptoms are not particularly troublesome. As each treatment can take over an hour, you must be comfortable lying within the MRIdian while holding your urine in for that length of time.

You may also be able to have radiotherapy on the MRIdian if you’ve already had radiotherapy to your prostate. You can find out more prostate re-irradiation here.

Your consultant will discuss your prostate cancer diagnosis, treatments to date and overall health with a multidisciplinary team of oncologists (doctors who specialise in cancer) and urologists (surgeons who specialise in urology conditions, including prostate cancer) to decide if this treatment is right for you. By working together, they’ll create a personalised treatment plan that may include radiotherapy, surgery and/or drug treatments. If they recommend that MRIdian is the best option for you, your oncologist will explain the treatment in detail to you and provide you with written information about what to expect, as well as give you plenty of opportunity to ask questions.

The MRIdian is just one of a number of treatment options that GenesisCare offer for prostate cancer. Having your treatment at GenesisCare also means access to integrated cancer care, such as psychological support and wellbeing services, which have been shown to reduce the burden of cancer and improve your quality of life outcomes after treatment.

This is our commitment to offer world-class care to every patient with cancer.

What are the side effects of prostate radiotherapy with the MRIdian?

Both surgery and radiotherapy carry risks of damage to the surrounding organs including incontinence, impotence and diarrhoea. The precision of MRIdian radiotherapy means you can expect these side effects to be reduced. A study from VU University Medical Centre in Amsterdam showed a low occurrence of bowel and urinary side effects in patient-reported and clinician-reported outcomes (1).

With MRIdian, side effects are fewer and less severe than with conventional radiotherapy. However, you may still experience some of the following side effects.

References

  1. Bruynzeel A, Tetar S, Oei S, Senan S, Haasbeek C, Spoelstra F et al. A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results. International Journal of Radiation Oncology Biology Physics. 2019;105(5):1086-1094.

Radiotherapy for prostate cancer treatment

Here is an outline of what to expect after your initial consultation and before, during and after your treatment. There are four stages to the process: your planning appointment, planning, treatment and follow-up. Before your first appointment, your care team will call you to explain any preparation instructions in advance of your appointments and to answer any questions.

GenesisCare centre in Oxford
/content/dam/asset-migration/centres-and-staff/uk-centres-and-staff/UK_Oncology_Centre%20profile_GA_Oxford_4.jpeg

Our GenesisCare centre in Oxford is rated ‘Good’ by the Care Quality Commission (CQC)

Our team of experts

To make sure you get the best treatment based on your needs, your consultant will work with a team of selected SABR consultants specialising in urology to review and plan your personalised treatment. This Urology SABR Advisory Team is made of leading consultants who have been selected based on their experience and clinical expertise and are listed below.

Dr Dan Ford

MBChB (Hons), BSc, MRCP, FRCR

Clinical oncologist

Dr Nicola Dallas

MBChB, MRCP, FRCR

Clinical Oncologist

Windsor +1

Dr Philip Camilleri

MD, MRCP, FRCR

Clinical Oncologist

Oxford +1

Dr Carla Perna

MBBS, FRCR (equiv.)

Clinical Oncologist

Guildford +2

Dr Prantik Das

MBBS, MRCP, FRCR

Clinical Oncologist

Nottingham +1

Enquire now about the MRIdian

The MRIdian is available at our centres in Oxford and Cromwell Hospital in London. Your cancer specialist can refer you for a consultation. We’re recognised by all major insurers and we’ll help you with transport depending on treatment and locations, when required.

Make an enquiry

Find a centre near you